Patent Law 8.26.04 Chakrabarty and its Progeny. “Old Business” P. 28 “Consisting of” transitional phrases Norian Corp. v. Stryker Corp., 70 USPQ2d 1508.

Slides:



Advertisements
Similar presentations
Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.
Advertisements

Introduction to Biotechnology
Science, Technology, and Society Integrated Science 9.
Mixtures & Solutions Biology.
Industrial Property the Patent system
Brainstorm: What are some ways that we contribute to the reduction in biodiversity of species?
Ethical Genetic Engineering? Michelle Seares, Dan Hussey, Robbie Canning The history of genetic engineering in humans can be traced back to the early 20.
Biopiracy Biopiracy is defined as, “the illegal appropriation of life – micro-organisms, plants and animals (including humans) and the traditional knowledge.
Patentable Subject Matter Prof Merges Agenda Old business: finish yesterday Introduction to patents Patentable subject matter.
Introduction to Genetics
Genetic Manipulation The New You of Tomorrow By: Vincent Zhu.
Chapter 7, section 3 questions
watch?v=EzEr23XJwFY. GENETICALLY MODIFIED ORGANISMS & BIOTECHNOLOGY.
Stem Cells and Cell Differentiation. 1. What are Stem Cells? a. Stem cells are different from all other cells in the body. b. Stem cells have 2 distinct.
Genetic Engineering: Transcription, Translation, and Genetically Modified Organisms.
Recombinant DNA and Cloning The Impact of Biotechnology Honors Genetics Ms. Susan Chabot Lemon Bay High School.
Biology and You I. Themes of Biology Biology-the study of life.
Chapter 13 Section 4 Applications of Genetic Engineering
As we all know, animal cloning has been the concern of science community and also the subject of scientific experiments for years. What uses does it have?
Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings PowerPoint® Lectures Lectures by Chris Romero, Front Range Community College Pandora’s.
Broadening the Scope of the Claims in Gene Therapy Applications Deborah Reynolds Detailee, TCPS
Innovation Economics (Pt. 2): “Push” Mechanisms, Mostly Private-Public Partnerships Private-Public Partnerships Stephen M. Maurer Designing Strategies.
Cloning & Gene Therapy Notes
Patentable Subject Matter Prof Merges Agenda Current § 101 Controversies Intro to patentable subject matter – Chakrabarty and Parke-Davis.
THE GREAT DEBATE!. Debate Topic A Should reproductive technology continue to be explored and implemented using information from the Human Genome Project.
Stem Cells Stem cells are immature cells that have not turned into specific cells yet; they haven’t become blood or skin, or anything else Stem cells.
Introductory course on Competition and Regulation Pál Belényesi University of Verona October 2006.
Intellectual Property, Patents & Technology Transfer Sagar Manoli Shashidhar, Philippe Abdel-Sayed Responsible Conduct in Biomedical Research EPFL,
Chapter 10 Principles of Evolution
28.1 Life in the Universe Are we alone?. Cosmic Evolution History of the universe History of the universe Particulate Particulate Galactic Galactic Stellar.
The BIG idea CHAPTER OUTLINE The body develops and maintains itself over time. The human body changes over time. 5.1 Systems in the body function to maintain.
Patents VI Infringement & the Doctrine of Equivalents Class 16 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
© 2011 Dannemann Siemsen. Todos os direitos reservados. Biotech IP issues in Brazil Gustavo Morais May 2011 Gustavo Morais May 2011.
Exploring American History Unit X – Modern America Chapter 31– America Looks to the Future Section 3 – The Road Ahead.
LIVE ON CLONING ENTERPRISES
Biotechnology is the use of organisms. Biotechnology has to do with genetic engineering.
Stem Cells and Society  Catalyst:  Describe one example of how genetic testing could be used to help someone.  Describe one example of how gene therapy.
Unit 3 science versus nature 高二必修 5. Unit 3 science versus nature Pre-reading Human Cloning BANNED.
Biotechnology Chemical Pharmaceutical Customer Partnership
1 Ch 14 Notes I. Mutations A. Def - a change in the ___________or ___________ of the genetic material of an organism. B. Causes 1. __________ – factors.
Ecology The study of how organisms interact with living and non- living aspects of their environment.
HC70A Winter 2006 Genetic Engineering in Medicine, Agriculture, and Law Professor Bob Goldberg Class Announcements 2/28/06.
Recombinant DNA and Cloning The Impact of Biotechnology Honors Genetics Ms. Susan Chabot Lemon Bay High School.
Cloning What’s a clone? How do you make one? What are the ethical issues in genetic engineering?
13-4: Genetic Engineering. GMOs Genetically Modified Organisms.
3 RD BLOCK WARM-UP 1. Have out your homework (Graphic Organizer). 2. After I check it, go check your answers at the SSS. 3. Open your Biology Handbook.
Biotechnology Chapter 1
Chapter 15: Genetic Engineering
Chapter 1: Moving Toward a New Way of Living 1 C H A P T E R Moving Toward a New Way of Living.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
Introduction The Patentability of Human Genes Is patenting human genes moral? Should it be legal? Should there be international intervention?
Introduction to Biotechnology. What is Biotechnology? Biotechnology is the manipulation of living organisms and organic material to serve human needs.
Biotechnology: using living systems to improve human life.
Basse Asplund, M Sc, Ph D Patent Attorney and Partner Stockholm, Uppsala, Göteborg och Lund.
Chapter 17 (pgs.445FL1-471) The Economic System. Chapter 17 Section 1 (pgs ) The Economic System at Work ESSENTIAL QUESTION: WHAT ARE THE DIFFERENT.
Competition and Intellectual Property Protection in the Pharmaceutical Sector Alexey Ivanov Director, HSE-Skolkovo Institute for Law and Development Director,
Biotechnology Is simply introducing foreign DNA into an organism in order to modify the organism’s DNA to produce a better desired result.
5th Grade Physical Science Lesson #4
Biotechnology Unit.
Biotechnology Chemical Pharmaceutical Customer Partnership
An Introduction to Medicinal Chemistry 3/e
THE GIFT OF LIFE— Applications of Reproductive Technology
THE GIFT OF LIFE.
DNA Structure and Function
Introduction to Biotechnology
Gene therapy Gene therapy aims to treat a disease by supplying a functional allele One possible procedure Clone the functional allele and insert it in.
Genetic Engineering.
Introduction to Biotechnology
THE GIFT OF LIFE.
Mutations, Genetic Engineering, & Cloning
Presentation transcript:

Patent Law Chakrabarty and its Progeny

“Old Business” P. 28 “Consisting of” transitional phrases Norian Corp. v. Stryker Corp., 70 USPQ2d 1508 (CA FC 2004) Use of term “consisting of” limits claimed invention by indicating that it contains only what is expressly set forth in claim, but term does not limit aspects unrelated to invention.

Norian v Stryker (cont’d) Patent No. 5,336,264 (the '264 patent): 8. A kit for preparing a calcium phosphate mineral, said kit consisting of: at least one calcium source and at least one phosphoric acid source free of uncombined water as dry ingredients; and a solution consisting of water and a sodium phosphate, where the concentration of said sodium phosphate in said water ranges from 0.01 to 2.0 M and said solution has a pH in the range of about 6 to 11.

Norian v. Stryker, cont’d In October 1999 Stryker began to market a BoneSource® kit that contained the sodium phosphate component as well as the mixture of tetracalcium phosphate and dicalcium phosphate; the kit also provided instructions for combining the components and a spatula for mixing them.

Norian v Stryker - holding [W]hile “consisting of” limits the claimed invention, it does not limit aspects unrelated to the invention. It is thus necessary to determine what is limited by the “consisting of” phrase... It is undisputed that the BoneSource® kit contains the same chemicals as set forth in claims 8-10 of the '065 patent. Infringement is not avoided by the presence of a spatula, for the spatula has no interaction with the chemicals, and is irrelevant to the invention.

Doctrine: Quick Summary Process patent – never a problem –Why not? P 68: Legislative history  statutory language –“Anything under the sun that is made by [humans]”

Doctrine II “Made by [humans]” –How does this limit the scope of patent law? –Is it predictable? Too open-ended?

Doctrine III P 68: The exceptions –What are they? –How do they square with the quasi-statutory language “anything under the sun...”

Doctrine IV Fleshing out the test... Redrafting the quasi-statute...

Doctrine IV Fleshing out the test... Redrafting the quasi-statute... Substantial Human Intervention?

The Life Sciences and § 101 A Brief history –Plant-specific acts, 1930 & 1970 –Early biotech – –Early animal modification: Ex parte Allen, 1987 –Gene patents: 1990-today –Gene therapy: mid-1990s-today –Dolly the sheep: late 1990s –Stem cell research: late 1990s-today

Commoncouragepress.com

Somebody owns your genes. Through the U.S. patent system, corporations and universities have claimed property rights not just on the rice and corn at your dinner table but also on you. Moving beyond patenting and "owning" diseases like staph, tuberculosis, and SARS, one American corporation owns the genetic heritage of the entire population of Iceland. A university has property rights on all human clones-even though human cloning is still being debated in Congress. Another company claims to have invented "junk" DNA. Through its patents, it stakes a claim to the research on 95% of human DNA.

Profits Pending examines the devastating affects of these patents on life, from the blatant theft of cultural resources to slowing down research into deadly diseases. Once used to reward the inventiveness of American scientists and entrepreneurs, the patent system is now being abused to control scientific exploration into human biology and to create monopolies over the world's food sources. Instead of promoting scientific research, patents on life now destroy crucial elements of the scientific method such as the free exchange of ideas between researchers. Profits Pending demonstrates that patents on life may ultimately destroy the biotechnology industry and ultimately hinder the innovation the American economy depends on.

Though we are only at the earliest stage of the establishment of patent monopolies over genes, cell lines, and even organisms, the current struggle over access to AIDS drugs is a harbinger of problems ahead. AIDS drug costs are a clear example of the use of patent monopolies to drive up the price of therapy.

Current Controversies The “Weldon Amendment” – passed late 2003 Bars the U.S. Patent Office from issuing any patent on any "human organism," meaning a member of the human species at any stage of development, including a human embryo or fetus. This "non-patentability" covers members of the species Homo sapiens who are created by human cloning, by in vitro fertilization, or by any other process.

Does Weldon Amendment Change the Law? PTO post-Allen policy announcement Does Weldon amendment go further? What is the best response on the part of industry, scientific community?